Nectar Lifesciences Ltd has announced an ₹81-crore share buyback, approved by its board at a meeting held on Wednesday, December 3, 2025.

The company will repurchase three crore fully paid-up equity shares at ₹27 per share through the tender offer route, representing up to 13.38% of its paid-up equity capital.

The buyback size is within the 10% limit of its total paid-up capital and free reserves based on FY25 audited financials.

According to the exchange filing, the buyback will be open to all eligible shareholders except promoters and promoter group members, who have formally expressed their intention not to participate.

The company has appointed Master Capital Services Ltd as the manager to the buyback. The record date to determine shareholder eligibility has been fixed as December

See Full Page